Skip to content

diversity

CRIO Company News 3 Minute Read

CRIO Announces Partnership with Pluto Health to Expand and Accelerate Clinical Trial Access

Innovative solution benefits patients with access to clinical trials as a treatment option, ongoing personalized health insights, and ultimately speeding new treatments to market  BOSTON, MA, July 19, 2023 – CRIO, a Boston-based healthcare technology company, in partnership with Pluto Health, a Durham, NC-based smart care coordination service company, announces the development of a scalable...

Recruitment & Diversity
4 Minute Read -

CRIO Sites Have Twice the Average Patient Diversity

The new FDA guidance to enhance diversity in clinical research subjects has brought ethnic and racial diversity to the center stage for sponsors.  In this document, the FDA encourages sponsors to develop a Race and Ethnic Diversity Plan to incorporate into each protocol. More specifically, the FDA suggests that to achieve these diversity targets, sponsors...

Recruitment & Diversity
4 Minute Read -

Increasing Diversity in Clinical Trials – 3 Steps for Sponsors

Overview This past April, the FDA released updated guidance to sponsors and pharmaceutical companies on increasing racial and ethnic diversity in clinical trials to propel more inclusive research. Racial and ethnic minorities have historically been underrepresented in research,1 even within diseases where they make up the majority of those affected. The FDA also advises sponsors...

Running a Study
4 Minute Read -

It’s not about DCT – Diversity Driven Clinical Trials are the Key

ASK ME ANYTHING WITH JONATHAN ANDRUS Jonathan Andrus, President & COO at CRIO, is an active thought-leader and presenter in the life sciences industry. He serves on the board and executive committee of the Society for Clinical Data Management (SCDM) and is co-lead with the Decentralized Trials and Research Alliance (DTRA) workstream initiative. In this...

Get articles delivered to your inbox, every week